Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rossi

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Bcl-2 protein in 518A2 melanoma cells in vivo and in vitroLuba Benimetskaya, Kanyalakshmi Ayyanar, Noah Kornblum, et al.
Oligonucleotides|March 25, 2005
Ribozyme cleavage leads to decreased expression of fibroblast growth factor receptor 3 in human multiple myeloma cells, which is associated with apoptosis and downregulation of vascular endothelial growth factorShenxian Qian, George Somlo, Bingsen Zhou, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectorsDavid Strayer, Francisco Branco, Mark A Zern, et al.
Molecular Therapy. Nucleic Acids|August 27, 2025
Development of conditional-siRNA programmable riboswitch for targeting adverse cardiac remodelingPriyanka Gokulnath, Ane M Salvador, Caleb Graham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2017
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell TherapyJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Haematologica|August 1, 2020
Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapyRanjit Nair, Gaëlle Drillet, Faustine Lhomme, et al.
The Journal of Biological Chemistry|May 25, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Journal of Clinical Pharmacology|July 29, 2010
Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitorJohn P Gibbs, Maurice G Emery, Ian McCaffery, et al.
Vascular|April 15, 2021
Optimization of factors for the prevention of spinal cord ischemia in thoracic endovascular aortic repairMichelle C Sulzinski, Matthew John Rossi, Abdullah A Alfawaz, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Bcl-2 protein in 518A2 melanoma cells in vivo and in vitroLuba Benimetskaya, Kanyalakshmi Ayyanar, Noah Kornblum, et al.
Oligonucleotides|March 25, 2005
Ribozyme cleavage leads to decreased expression of fibroblast growth factor receptor 3 in human multiple myeloma cells, which is associated with apoptosis and downregulation of vascular endothelial growth factorShenxian Qian, George Somlo, Bingsen Zhou, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Durability of transgene expression and vector integration: recombinant SV40-derived gene therapy vectorsDavid Strayer, Francisco Branco, Mark A Zern, et al.
Molecular Therapy. Nucleic Acids|August 27, 2025
Development of conditional-siRNA programmable riboswitch for targeting adverse cardiac remodelingPriyanka Gokulnath, Ane M Salvador, Caleb Graham, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 15, 2017
Long-Duration Complete Remissions of Diffuse Large B Cell Lymphoma after Anti-CD19 Chimeric Antigen Receptor T Cell TherapyJames N Kochenderfer, Robert P T Somerville, Tangying Lu, et al.
Haematologica|August 1, 2020
Acute leucoencephalomyelopathy and quadriparesis after CAR T-cell therapyRanjit Nair, Gaëlle Drillet, Faustine Lhomme, et al.
The Journal of Biological Chemistry|May 25, 2025
Cryo-EM structures reveal the PP2A-B55α and Eya3 interaction that can be disrupted by a peptide inhibitorShasha Shi, Xueni Li, Christopher Alderman, et al.
Journal of Clinical Pharmacology|July 29, 2010
Population pharmacokinetic/pharmacodynamic model of subcutaneous adipose 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity after oral administration of AMG 221, a selective 11β-HSD1 inhibitorJohn P Gibbs, Maurice G Emery, Ian McCaffery, et al.
Vascular|April 15, 2021
Optimization of factors for the prevention of spinal cord ischemia in thoracic endovascular aortic repairMichelle C Sulzinski, Matthew John Rossi, Abdullah A Alfawaz, et al.
Pageof 9